Viewing Study NCT02333708


Ignite Creation Date: 2025-12-26 @ 10:58 AM
Ignite Modification Date: 2026-01-13 @ 6:10 PM
Study NCT ID: NCT02333708
Status: UNKNOWN
Last Update Posted: 2022-03-09
First Post: 2015-01-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Circulating Microparticles in Giant Cell Arteritis
Sponsor:
Organization:

Raw JSON

{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D013700', 'term': 'Giant Cell Arteritis'}], 'ancestors': [{'id': 'D020293', 'term': 'Vasculitis, Central Nervous System'}, {'id': 'D020274', 'term': 'Autoimmune Diseases of the Nervous System'}, {'id': 'D009422', 'term': 'Nervous System Diseases'}, {'id': 'D002561', 'term': 'Cerebrovascular Disorders'}, {'id': 'D001927', 'term': 'Brain Diseases'}, {'id': 'D002493', 'term': 'Central Nervous System Diseases'}, {'id': 'D014652', 'term': 'Vascular Diseases'}, {'id': 'D002318', 'term': 'Cardiovascular Diseases'}, {'id': 'D001167', 'term': 'Arteritis'}, {'id': 'D014657', 'term': 'Vasculitis'}, {'id': 'D017445', 'term': 'Skin Diseases, Vascular'}, {'id': 'D012871', 'term': 'Skin Diseases'}, {'id': 'D017437', 'term': 'Skin and Connective Tissue Diseases'}, {'id': 'D001327', 'term': 'Autoimmune Diseases'}, {'id': 'D007154', 'term': 'Immune System Diseases'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D001800', 'term': 'Blood Specimen Collection'}], 'ancestors': [{'id': 'D013048', 'term': 'Specimen Handling'}, {'id': 'D019411', 'term': 'Clinical Laboratory Techniques'}, {'id': 'D019937', 'term': 'Diagnostic Techniques and Procedures'}, {'id': 'D003933', 'term': 'Diagnosis'}, {'id': 'D011677', 'term': 'Punctures'}, {'id': 'D013514', 'term': 'Surgical Procedures, Operative'}, {'id': 'D008919', 'term': 'Investigative Techniques'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'CASE_CONTROL'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 75}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'RECRUITING', 'startDateStruct': {'date': '2015-09'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2016-09', 'completionDateStruct': {'date': '2023-11', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2022-03-08', 'studyFirstSubmitDate': '2015-01-05', 'studyFirstSubmitQcDate': '2015-01-06', 'lastUpdatePostDateStruct': {'date': '2022-03-09', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2015-01-07', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2023-09-16', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Level of microparticles in the blood of patients with histologically proven giant cell arteritis.', 'timeFrame': 'Baseline', 'description': 'Level of microparticles (MPs) in the blood of patients with histologically proven giant cell arteritis (GCA), compared with patients matched for age, sex and with or without inflammatory syndrome.'}]}, 'conditionsModule': {'conditions': ['Giant Cell Arteritis', 'Acute Phase']}, 'descriptionModule': {'briefSummary': 'To demonstrate that microparticles (MPs), having a powerful procoagulant potential, are in larger amounts in the blood of patients with histologically proven giant cell arteritis (GCA), compared with patients matched for age, sex and with or without inflammatory syndrome.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'primary and secondary care hospital', 'healthyVolunteers': True, 'eligibilityCriteria': 'For GCA group:\n\nInclusion Criteria:\n\n* Men and women ≥ 18 years of age Patient affiliated to social security regimen\n* Informed and having signed the consent form to take part in the study.\n* Diagnosis of GCA, meeting at least 3 of the following 5 American College of Rheumatology (ACR) criteria for the diagnosis of GCA, including inflammatory syndrome and having\n\n * Either temporal artery biopsy showing characteristic GCA abnormality\n * Or inflammatory arteritis on imaging examination\n\nExclusion Criteria:\n\n* Persons under protection of the court or guardianship\n* Inability to understand or to follow study procedures\n* Dementia\n* cancer diagnosed within the previous 5 years (except for non-melanoma skin cancer or in situ carcinoma of the cervix)non-contributory or inconclusive temporal artery biopsy\n* Any conditions that might interfere with MPs level: diabetes, recent endo-arterial gesture, current treatment with corticosteroids.\n* Participation in another ongoing clinical trial Current anticoagulant therapy\n* Active infectious disease'}, 'identificationModule': {'nctId': 'NCT02333708', 'acronym': 'MicroGiant', 'briefTitle': 'Study of Circulating Microparticles in Giant Cell Arteritis', 'organization': {'class': 'OTHER', 'fullName': 'University Hospital, Caen'}, 'officialTitle': 'Study of Circulating Microparticles in Giant Cell Arteritis', 'orgStudyIdInfo': {'id': '2013-A00273-44'}}, 'armsInterventionsModule': {'armGroups': [{'label': 'GCA group', 'interventionNames': ['Other: Blood sample']}, {'label': 'Inflammatory syndrome (without GCA) group', 'interventionNames': ['Other: Blood sample']}, {'label': 'Without inflammatory syndrome and without GCA group', 'interventionNames': ['Other: Blood sample']}], 'interventions': [{'name': 'Blood sample', 'type': 'OTHER', 'armGroupLabels': ['GCA group', 'Inflammatory syndrome (without GCA) group', 'Without inflammatory syndrome and without GCA group']}]}, 'contactsLocationsModule': {'locations': [{'zip': '14000', 'city': 'Caen', 'status': 'RECRUITING', 'country': 'France', 'contacts': [{'name': 'Boris BIENVENU', 'role': 'CONTACT', 'phone': '+33231064579'}], 'facility': 'Centre Hospitalier Universitaire Côte de Nacre', 'geoPoint': {'lat': 49.18585, 'lon': -0.35912}}], 'centralContacts': [{'name': 'Boris BIENVENU, MD, PhD,', 'role': 'CONTACT', 'email': 'bienvenu-b@chu-caen.fr', 'phone': '+33231064579'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'University Hospital, Caen', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}